BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 368,400 shares, a growth of 58.7% from the March 31st total of 232,200 shares. Based on an average trading volume of 366,100 shares, the short-interest ratio is currently 1.0 days.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

A number of hedge funds have recently added to or reduced their stakes in the stock. Estabrook Capital Management acquired a new stake in shares of BlackRock Health Sciences Term Trust in the 4th quarter worth about $35,000. CWM LLC increased its stake in shares of BlackRock Health Sciences Term Trust by 177.9% in the first quarter. CWM LLC now owns 2,596 shares of the company’s stock valued at $39,000 after purchasing an additional 1,662 shares during the period. Elequin Capital LP acquired a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter valued at approximately $84,000. Yakira Capital Management Inc. acquired a new position in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth approximately $153,000. Finally, Virtu Financial LLC bought a new position in BlackRock Health Sciences Term Trust in the 4th quarter worth approximately $206,000.

BlackRock Health Sciences Term Trust Stock Performance

Shares of BMEZ stock opened at $14.65 on Friday. The business has a 50 day moving average of $14.63 and a two-hundred day moving average of $15.25. BlackRock Health Sciences Term Trust has a 52 week low of $12.58 and a 52 week high of $16.75.

BlackRock Health Sciences Term Trust Cuts Dividend

The business also recently disclosed a monthly dividend, which was paid on Wednesday, April 30th. Investors of record on Tuesday, April 15th were paid a dividend of $0.174 per share. The ex-dividend date was Tuesday, April 15th. This represents a $2.09 dividend on an annualized basis and a yield of 14.25%.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.